SBIR Phase II: Electric Blower-Based Emergency Mask Ventilator for Simple Ventilation and Monitoring During Patient Distress and Transport

这项小型企业创新研究（SBIR）第二阶段项目的更广泛影响/商业潜力正在简化一项困难和危险的医疗干预，该干预在美国每年进行数百万次，具有便携式和符合人体工程学的设备，使救援人员能够在需要通气辅助的紧急情况下提高每位患者的安全性。由此产生的设备将减少在每一秒都对患者健康至关重要的情况下稳定患者所需的时间。 该设备还将使响应者能够更有效、更安全地完成工作。由此产生的技术不仅旨在提高患者的安全性和医疗响应者的效率，而且还旨在以具有成本效益的方式实现这一目标。这项研究的主要重点是开发一种适用于所有紧急情况和每一位需要救援通气的患者的解决方案。该小型企业创新研究（SBIR）第二阶段项目将开发和测试一种设备，该设备将计算和测量救援通气期间输送的潮气量，并向响应者提供即时反馈，以评估患者呼吸系统的状态。该设备将使用严格控制的压力水平和呼吸速率输送呼吸，以避免伤害患者，同时还提供优化的通气。它将提供这些功能，在一个小的，符合人体工程学，便携式的形式因素，可以很容易地使用一只手左右，从而提高灵活性和自由的响应者处理其他问题。本项目第一阶段的开发和客户数据将用于全面构建适用于FDA验证测试和批准的操作原型。通过将如此高水平的呼吸护理集成到便携式设备中，这种技术的影响将扩大到所有需要救生通气的患者。该奖项反映了NSF的法定使命，并通过使用基金会的知识价值和更广泛的影响审查标准进行评估，被认为值得支持。

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is simplifying a difficult and dangerous medical intervention, that is performed millions of times a year in the United States, with a portable and ergonomic device that enables rescuers to increase the safety for every patient in an emergency that requires ventilation assistance. The resulting device will decrease the time necessary to stabilize a patient during situations where every second is crucial to the patient’s health. The device will also enable responders to accomplish their jobs more effectively and safely. The resulting technology seeks not only to increase safety for patients and increase efficiency of medical responders, but it seeks to do so in a cost-effective manner. A main focus of this research is to develop a solution applies in all emergency situations and for every patient requiring rescue ventilation. This Small Business Innovation Research (SBIR) Phase II project will develop and test a device that will calculate and measure the tidal volume delivered during rescue ventilation and provide instant feedback to the responder to evaluate the status of the patient’s respiratory system. The device will deliver breaths using tightly controlled pressure levels and respiration rates to avoid injuring the patient while also providing optimized ventilation. It will provide these features in a small, ergonomic, portable form-factor that can easily be used ambidextrously with one hand, thereby improving the flexibility and freedom of the responder to deal with other issues. The development and customer data from Phase I of this project will be used to fully construct an operational prototype that will be suitable for FDA validation testing and clearance. By integrating such a high level of respiratory care into a portable device, the impact of such technology will be broadened to all patients that require live-saving ventilation.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.